PTSD clinical trials
Showing 101–150 of 362 active trials. Describe your situation to see which ones you may be eligible for.
- Considering Racial and Acculturation Stress in Addressing Trauma
- Cognitive Processing Therapy (CPT) Memory Support (MS) Study
- Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients
- A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD
- Warrior CARE: Cannabis Behavioral Health
- Treatment for PTSD and Tinnitus
- Treatment for Antepartum Posttraumatic Stress Disorder/PTSD Study
- Enhancing PTSD Treatment Outcomes by Improving Patient-Provider Communication
- Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults
- Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure
- Cognitive Processing Therapy (CPT) for Perinatal Posttraumatic Stress Disorder (PTSD)
- Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- Written Exposure Therapy for Veterans With SUD and PTSD
- Treatments for Insomnia in Veterans With PTSD
- Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
- Family Involvement in Treatment for PTSD (FIT-PTSD): A Brief, Feasible Method for Enhancing Outcomes, Retention, and Engagement
- Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder
- Targeted Plasticity Therapy for PTSD
- Repurposing Low-Dose Clonidine for PTSD in Veterans
- Mobile Anger Reduction Intervention
- Advanced Wireless Augmented Reality-Enhanced Exposure Therapy for Posttraumatic Stress Disorder
- Combining Stellate Ganglion Block With Prolonged Exposure for PTSD
- Exercise and Emotional Learning in Posttraumatic Stress Disorder
- Manage Emotions to Reduce Aggression (MERA)
- Testing a Scalable Model of Care to Improve Patients Access to Mental Health Services After Traumatic Injury
- Investigating Cardiac Health of Adults With Trauma
- Pimavanserin for Insomnia in Veterans With PTSD
- NightWare and Cardiovascular Health in Veterans With PTSD
- Enhancing Week-long Psychological Treatment for PTSD With Ketamine
- Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
- Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
- Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
- State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma
- Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers
- Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
- Transcutaneous Vagal Nerve Stimulation in Veterans With Posttraumatic Stress Disorder
- Transcranial Magnetic Stimulation in Veterans With PTSD
- Disrupting Fear-based Memory Consolidation
- A Neurosensory Account of Anxiety and Stress (Study 2)
- Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
- Computer Monitor vs Augmented Reality 3MDR for PTSD PTSD: A Randomized Controlled Trial
- A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations
- A Neurosensory Account of Anxiety and Stress (Study 1)
- Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD
- Mechanisms Underlying Efficacy of Prolonged Exposure
- Intensive Multi-Couple Therapy for PTSD Versus Relationship Education in Military Couples
- Evaluating Treatments for Suicidal Veterans With PTSD
- Safe Mothers, Safe Children Initiative
- General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to Occupational Trauma
- Safe & Sound Protocol in Adults With Trauma and SUD
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.